Related Experiment Video
Updated: Feb 2, 2026

Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025
An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood
Imran Uddin1, Kroopa Joshi2, Theres Oakes1
1Division of Infection and Immunity, UCL, London, UK.
Abstract:
The T cell receptor repertoire provides a window to the cellular adaptive immune response within a tumor, and has the potential to identify specific and personalized biomarkers for tracking host responses during cancer therapy, including immunotherapy. We describe a protocol for amplifying, sequencing, and analyzing T cell receptors which is economical, robust, sensitive, and versatile. The key experimental step is the ligation of a single-stranded oligonucleotide to the 3' end of the T cell receptor cDNA, which allows easy amplification of all possible rearrangements using only a single set of primers per locus, while simultaneously introducing a unique molecular identifier to label each starting cDNA molecule. After sequencing, this molecular identifier can be used to correct both sequence errors and the effects of differential PCR amplification efficiency, thus producing a more accurate measure of the true T cell receptor frequency within the sample. This method has been applied to the analysis of unfractionated human tumor lysates, subpopulations of tumor-infiltrating lymphocytes, and peripheral blood samples from patients with a variety of solid tumors.
Insights
This study presents a cost-effective and accurate method for analyzing T cell receptor repertoires in tumors. This approach enhances the identification of personalized biomarkers for tracking immune responses during cancer therapy.
Area of Science:
- Immunology
- Oncology
- Genomics
Background:
- The T cell receptor (TCR) repertoire reflects the adaptive immune response within tumors.
- TCR analysis holds potential for personalized biomarkers in cancer therapy, particularly immunotherapy.
- Accurate quantification of TCR frequencies is crucial for monitoring treatment efficacy.
Purpose of the Study:
- To describe a novel, economical, robust, sensitive, and versatile protocol for TCR repertoire amplification, sequencing, and analysis.
- To enable accurate measurement of TCR frequencies for tracking host responses in cancer patients.
Main Methods:
- A key step involves ligating a single-stranded oligonucleotide to the 3' end of TCR cDNA.
- This enables amplification of all TCR rearrangements with a single primer set per locus.
- Unique molecular identifiers (UMIs) are incorporated to label each starting cDNA molecule for error correction.
Main Results:
- The UMI-based approach corrects for sequence errors and differential PCR amplification bias.
- This leads to a more accurate assessment of true TCR frequencies in biological samples.
- The method was successfully applied to human tumor lysates, tumor-infiltrating lymphocytes, and peripheral blood.
Conclusions:
- The described protocol provides an accurate and efficient method for TCR repertoire analysis.
- This technique can be utilized for developing personalized biomarkers in cancer immunotherapy.
- The versatility of the method supports its application across various sample types from cancer patients.
More Related Videos
Related Concept Videos
Signal Sequences and Sorting Receptors
Quantitative Aspects of Drug-Receptor Interaction
Internal Receptors
Types of Receptors: Cell Surface Receptors
Receptor-mediated Endocytosis
Cis-regulatory Sequences

